Advertisement
Techniques & methods| Volume 48, ISSUE 4, P310-314, August 15, 2000

Download started.

Ok

Plasma adrenocorticotropin responses to opioid blockade with naloxone: generating a dose–response curve in a single session

      Abstract

      We examined two methods of generating a dose–response curve to the opioid receptor antagonist naloxone. In 15 healthy male subjects (18–25 years) plasma adrenocorticotropin (ACTH) responses to five doses of naloxone studied over 5 separate days were compared to plasma ACTH responses to five incremental doses of naloxone studied within a single session. There was a statistically significant positive correlation in ACTH responses (area under the curve and peak) between dosing methods. Furthermore, the doses of naloxone that produced half-maximal and maximal ACTH response were similar. The comparability of ACTH responses between the two naloxone dosing techniques, combined with the safety and ease associated with the single-session methodology, underscores the usefulness of the single-session technique for future investigations.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Campbell M.
        • Harris J.C.
        Resolved.
        J Am Acad Child Adolesc Psychiatry. 1996; 35: 246-249
        • Carrion V.G.
        Naltrexone for the treatment of trichotillomania.
        J Clin Psychopharmacol. 1995; 15: 444-445
        • Cohen M.R.
        • Cohen R.M.
        • Pickar D.
        • Weingartner H.
        • Murphy D.L.
        High-dose naloxone infusions in normals.
        Arch Gen Psychiatry. 1983; 40: 613-619
        • Genazzani A.D.
        • Gastaldi M.
        • Petraglia F.
        • Battaglia C.
        • Surico N.
        • Volpe A.
        • et al.
        Naltrexone administration modulates the neuroendocrine control of LH secretion in hypothalamic amenorrhea.
        Hum Reprod. 1995; 10: 2868-2871
        • Gillman M.A.
        • Sandyk R.
        Tourette syndrome and the opioid system.
        Psychiatr Res. 1985; 15: 161-162
        • Inder W.
        • Joyce P.
        • Ellis M.
        • Evans M.
        • Livesey J.
        • Donald R.
        The effects of alcoholism on the hypothalamic-pituitary-adrenal axis.
        J Clin Endocrinol Metab. 1995; 43: 283-290
        • Introini-Collison I.B.
        • Ford L.
        • McGaugh J.L.
        Memory impairment induced by intraamygdal β-endorphin is mediated by noradrenergic influences.
        Neurobiol Learn Mem. 1995; 63: 200-205
        • Izquierdo I.
        Beta-endorphin and forgetting.
        Trends Pharmacol Sci. 1982; 3: 455-457
        • Kars H.
        • Broekema W.
        • Glaudemans-van-Gelderen I.
        • Verhoeven W.M.A.
        • Van Ree J.M.
        Naltrexone attenuates self-injurious behavior in mentally retarded subjects.
        Biol Psychiatry. 1990; 27: 741-746
        • Kaye W.H.
        • Berrettini W.H.
        • Gwirtsman H.E.
        • Chretien M.
        • Gold P.W.
        • George D.T.
        • et al.
        Reduced cerebrospinal fluid levels of immunoreactive pro-opiomelanocortin related peptides (including β-endorphin) in anorexia nervosa.
        Life Sci. 1987; 41: 2147-2155
        • Keuler D.J.
        • Altemus M.
        • Michelson D.
        • Greenberg B.
        • Murphy D.L.
        Behavioral effects of naloxone infusion in obsessive-compulsive disorder.
        Biol Psychiatry. 1996; 40: 154-156
        • Lienemann J.
        • Walker F.
        Naltrexone for treatment of self-injury.
        Am J Psychiatry. 1989; 146: 639-640
        • Martin del Campo A.F.
        • Dowson J.H.
        • Herbert J.
        • Paykel E.S.
        Effects of naloxone on diurnal rhythms in mood and endocrine function.
        Psychopharmacology. 1994; 114: 583-590
        • Martin del Campo A.F.
        • McMurray F.
        • Besser G.M.
        • Grossman A.
        Effect of 12-hour infusion of naloxone on mood and cognition in normal male volunteers.
        Biol Psychiatry. 1992; 32: 344-353
        • McGaugh J.L.
        • Introini-Collison I.B.
        • Juler R.G.
        • Izquierdeo I.
        Striatal terminalis lesions attenuate the effects of postraining nalxone and β-endorphin on retention.
        Behav Neurosci. 1986; 100: 839-844
        • Michelson D.
        • Altemus M.
        • Galliven E.
        • Hill L.
        • Greenberg B.
        • Gold P.
        Naloxone-induced pituitary-adrenal activation does not differ in patients with depression, obsessive compulsive disorder and healthy controls.
        Neuropsychopharmacology. 1996; 15: 207-212
        • Olson G.A.
        • Olson R.D.
        • Kastin A.J.
        Endogenous opiates.
        Peptides. 1996; 17: 1421-1466
        • Waltman C.
        • Blevins L.S.
        • Boyd G.
        • Wand G.
        Effects of mild ethanol intoxication on the HPA axis in nonalcohlic men.
        J Clin Endocrinol Metab. 1993; 77: 518-522
        • Wand G.S.
        • Mangold D.
        • Ali M.
        Adrenocorticotropin responses to naloxone in sons of alcohol dependent men.
        J Clin Endocrinol Metab. 1999; 84: 64-68
        • Wand G.S.
        • Mangold D.L.
        • El Deiry S.
        • McCaul M.E.
        • Hoover D.
        Family history of alcoholism and hypothalamic opioidergic activity.
        Arch Gen Psychiatry. 1998; 55: 1114-1120